IL111909A0 - Combination preparations comprising a quinoxaline and a nucleoside - Google Patents

Combination preparations comprising a quinoxaline and a nucleoside

Info

Publication number
IL111909A0
IL111909A0 IL11190994A IL11190994A IL111909A0 IL 111909 A0 IL111909 A0 IL 111909A0 IL 11190994 A IL11190994 A IL 11190994A IL 11190994 A IL11190994 A IL 11190994A IL 111909 A0 IL111909 A0 IL 111909A0
Authority
IL
Israel
Prior art keywords
nucleoside
quinoxaline
combination preparations
formulae
substituents
Prior art date
Application number
IL11190994A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL111909A0 publication Critical patent/IL111909A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
IL11190994A 1993-12-09 1994-12-07 Combination preparations comprising a quinoxaline and a nucleoside IL111909A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4342024A DE4342024A1 (de) 1993-12-09 1993-12-09 Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid

Publications (1)

Publication Number Publication Date
IL111909A0 true IL111909A0 (en) 1995-03-15

Family

ID=6504591

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11190994A IL111909A0 (en) 1993-12-09 1994-12-07 Combination preparations comprising a quinoxaline and a nucleoside

Country Status (12)

Country Link
EP (1) EP0657166B1 (fr)
JP (1) JPH07196511A (fr)
KR (1) KR950016754A (fr)
CN (1) CN1108935A (fr)
AT (1) ATE236642T1 (fr)
AU (1) AU697486B2 (fr)
CA (1) CA2137605A1 (fr)
DE (2) DE4342024A1 (fr)
HU (1) HU221498B (fr)
IL (1) IL111909A0 (fr)
NZ (1) NZ270088A (fr)
ZA (1) ZA949785B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4437406A1 (de) * 1994-10-19 1996-04-25 Hoechst Ag Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19703131A1 (de) * 1997-01-29 1998-07-30 Bayer Ag Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
DE19727117A1 (de) * 1997-06-26 1999-01-07 Boehringer Ingelheim Pharma Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
WO1999025327A2 (fr) * 1997-11-14 1999-05-27 Warner-Lambert Company Intervention de petites molecules dans la replication du vih-1
CA2334332A1 (fr) * 1998-06-26 2000-01-06 Robert Joseph Mchugh Quinoxalin-2(1h)-ones substitues utilises comme inhibiteurs de transcriptase inverse du vih
GB9821000D0 (en) * 1998-09-28 1998-11-18 Glaxo Group Ltd Antiviral combinations
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
WO2005018531A2 (fr) * 2003-08-26 2005-03-03 'chemical Diversity Research Institute', Ltd. Compositions pharmaceutiques, composes azo-heterocycliques et procedes de fabrication et d'utilisation correspondants
CN1886389B (zh) * 2003-09-30 2010-07-21 詹森药业有限公司 喹喔啉化合物
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
EP3021847B1 (fr) * 2013-07-15 2023-06-07 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Dérivés de spiroquinoxaline en tant qu'inhibiteurs de la mort cellulaire régulée non apoptotique
WO2016075137A1 (fr) 2014-11-10 2016-05-19 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Dérivés de spiropyrazine en tant qu'inhibiteurs de la mort cellulaire régulée non apoptotique
DE102017005091A1 (de) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substituierte 3,4-Dihydropyrido[2,3-b]pyrazin-2(1H)-one
DE102017005089A1 (de) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substitulerte 3,4-Dihydrochinoxalin-2(1H)-one

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT509398E (pt) * 1991-04-15 2002-02-28 Aventis Pharma Gmbh Quinoxalinas processo para a sua preparacao e sua utilizacao

Also Published As

Publication number Publication date
ATE236642T1 (de) 2003-04-15
CA2137605A1 (fr) 1995-06-10
JPH07196511A (ja) 1995-08-01
HU221498B (en) 2002-10-28
AU8042194A (en) 1995-06-15
DE4342024A1 (de) 1995-06-14
AU697486B2 (en) 1998-10-08
HUT70037A (en) 1995-09-28
CN1108935A (zh) 1995-09-27
EP0657166B1 (fr) 2003-04-09
KR950016754A (ko) 1995-07-20
ZA949785B (en) 1995-07-12
EP0657166A1 (fr) 1995-06-14
NZ270088A (en) 1998-04-27
HU9403518D0 (en) 1995-02-28
DE59410271D1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
TW207533B (fr)
IL96882A0 (en) Uracil derivatives and pesticides containing the same as active ingredient
IL111909A0 (en) Combination preparations comprising a quinoxaline and a nucleoside
GEP20002331B (en) Alkylated Raphamicine Derivatives
AU2724292A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid
MX9204647A (es) Montaje de bolsa surtidora de producto.
ZA925128B (en) Pyrrolidine derivatives,their preparation and medicaments containing them
GR3007513T3 (fr)
EP0712853A4 (fr) Derive de pyrazole
IT1240336B (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
EP0411733A3 (en) 11-beta-aryle-gona-4,9-dien-3-ones
GR3017051T3 (en) Azeotropic or azeotropic-like composition of hydrochlorofluoropropane.
EP0522173A4 (en) 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof
IL104158A0 (en) Bicyclotridecenone compounds,their preparation and pharmaceutical compositions containing them
MY132057A (en) Quinoxalinones, a process for their preparation and their use
EP0638080A4 (fr) PYRIMIDINE 7-BISUBSTITUEE-METHYL-4-OXO-3H -, 5H --PYRROLO 3,2-d -], UTILISATION PHARMACEUTIQUE ET COMPOSITIONS CONTENANT LADITE PYRIMIDINE.
IL106147A0 (en) 4-iminoquinolines,processes for their preparation,and their use
ZA881430B (fr)
GR3031162T3 (en) Thiazolotriazole and thiazolodiazole derivatives with fungicidal activity.
HU9200916D0 (en) Antimicrobial preparations containing 3,4-dichlor-anilide- and izotiazolone derivatives
GR3031709T3 (en) Octahydro-2-naphthalenecarboxylic acid derivative, its production and use.
ITMI932019A0 (it) Composizione farmaceutica antivirale contenente la 2-ammino 4,6-dicloropirimidina e metisoprinolo
ITMI911344A1 (it) Associazione farmaceutica ad attivita' antineoplastica
CA1265160C (fr) Gem-dihalogeno- et gem-tetrahalogeno-1,12-diamino-4, 9-diaza-dodecanes